Katherine Levy
Apr 14, 2011

Novartis to review US$600m global media business

GLOBAL - Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated US$600 million global media business.

Novatris currently works with incumbent MEC
Novatris currently works with incumbent MEC

WPP's MEC is the incumbent on the global business.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

This article was first published on campaignlive.co.uk.

Source:
Campaign Asia

Related Articles

Just Published

12 hours ago

Japan drives Dentsu’s modest Q1 growth, APAC and ...

CXM struggles with double-digit declines globally, while media services provide steady growth.

16 hours ago

Publicis dominates latest global new-business media ...

Publicis Collective has leapt into the lead for May, following its win of Coca-Cola's business in North America, while 13 new agencies join the top 20.

16 hours ago

WPP Media: How did one of the world’s biggest comms ...

OPINION: Adland has been buzzing over the leaked news of GroupM’s rebrand. Is this WPP's bold reinvention or a sign of deeper troubles? TrinityP3's Darren Woolley looks at the communication missteps and what this shake-up means for advertisers, employees, and the future of media buying.

17 hours ago

LePub Singapore appoints Penny Sadlier as MD, makes ...

EXCLUSIVE: Sadlier's role expands within Publicis, and her leadership is bolstered with five key hires, including creative heavyweights from Ogilvy and MullenLowe.